knowledge -WSS

knowledge

author：focus 2025-09-14 21:42:54 - browse：67

Sarepta - Cambridge -AP — Kristoffer Tripplaar/Sipa via AP

The Food and Drug Administration granted conditional approval Thursday to the first gene therapy for Duchenne muscular dystrophy. Regulators restricted the treatment to younger patients, with additional data required to broaden its use.

The gene therapy, called Elevydis, is made by Sarepta Therapeutics. The company will charge $3.2 million for the treatment, making it the U.S.’s second most expensive drug, behind a recently approved gene therapy for hemophilia. CEO Doug Ingram said on a conference call the price was below what a recently published company-funded analysis found would be cost-effective.

“The approval of Elevidys is a watershed moment for the treatment of Duchenne. Elevydis is the first and only gene therapy approved for Duchenne, and this approval brings us closer to our goal of bringing forward a treatment that provides the potential to alter the trajectory of this degenerative disease,” Ingram said.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Federal judge rules Oregon’s tough new gun law is constitutional

WSS

National associations that represent hospice owe an apology

Can CDC director Mandy Cohen drive consensus in Washington?

DeSantis wants to import drugs. Biden’s FDA blasted his plan

As obesity drug market grows, telehealth companies court payers

Trump to be booked at notorious Fulton County Jail at center of DOJ probe

Does aspartame cause cancer? What new WHO guidance says

hotspot

knowledge

hotspot

Guidelines to prevent youth baseball injuries need more muscle

Grail faces three suits alleging harassment, retaliation

Alkermes shareholders re

Involuntary treatment for addiction doesn't work

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Grail faces three suits alleging harassment, retaliation

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Roche's accidental data boosts hopes for anti

At least 13 dead in Texas as scorching temps continue

Roche's accidental data boosts hopes for anti

focus

Medicare eyes cuts to doctors, raises to outpatient clinics in 2024

J&J expands global access to TB drug amid advocacy campaign

Can CDC director Mandy Cohen drive consensus in Washington?

Study: Spinal cord stimulation helps patients with paralysis walk again

Who gets to use the title 'doctor'?

DeSantis wants to import drugs. Biden’s FDA blasted his plan

leisure time

hotspot

leisure time

focus